International Journal of Hematology

, Volume 81, Issue 2, pp 94–99 | Cite as

The Effect of Antiplatelet Autoantibodies on Megakaryocytopoiesis

  • Robert McMillanEmail author
  • Diane Nugent


Immune thrombocytopenic purpura (ITP) is a disorder manifested by isolated thrombocytopenia. In vivo infusion studies in the 1950s and 1960s provided evidence that the thrombocytopenia was due to autoantibody-induced platelet destruction. However, there is mounting evidence that platelet production in this disorder may also be suppressed by antibodies. Early morphologic studies showed megakaryocytic damage in ITP, and these results have been confirmed by ultrastructural studies. Autologous platelet turnover studies in the 1980s showed that most ITP patients have either normal or reduced platelet turnover rather than increased turnover, as would be expected if platelet destruction were the only pathogenetic mechanism. More recently, in vitro culture studies of both adult and pediatric ITP have shown that some ITP plasmas suppress both megakaryocytopoiesis and thrombopoiesis. In view of these findings, both platelet destruction and suppression of platelet production seem likely to be involved in the pathogenesis of ITP.

Key words

ITP Antiplatelet antibody Immune thrombocytopenia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Frank E. Die essentielle Thrombopenie. (Konstitutionelle Purpura- Pseudohämophilie), I: Klinische Bild. Berl Klin Wochenschr. 1915;52:454–458.Google Scholar
  2. 2.
    Kaznelson P. Verschwinden der hämorrhagischen Diathese bei einem Falle von “essentieller Thrombopenie” (Frank) nach Milzexstirpation: Splenogene thrombolytische Purpura. Wien Klin Wochenschr. 1916;29:1451–1454.Google Scholar
  3. 3.
    Harrington WJ, Sprague CC, Minnich V, Moore CV, Aulvin RC, Dubach R. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med. 1953;38:433–469.CrossRefPubMedGoogle Scholar
  4. 4.
    Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic, and isotopic studies. Ann N Y Acad Sci. 1965;124:499–542.CrossRefPubMedGoogle Scholar
  5. 5.
    McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37:239–248.CrossRefPubMedGoogle Scholar
  6. 6.
    Firkin BG, Wright R, Miller S, Stokes E. Splenic macrophages in thrombocytopenia. Blood. 1969;33:240–245.PubMedGoogle Scholar
  7. 7.
    McMillan R, Longmire RL, Tavassoli M, Armstrong S, Yelenosky R. In vitro platelet phagocytosis by ITP splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med. 1974;290:249–251.CrossRefPubMedGoogle Scholar
  8. 8.
    Tsubakio T, Kurata Y, Kanayama Y, Yonezawa T, Tarui S, Kitani T. In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura. Acta Haematol. 1983;70:250–256.CrossRefPubMedGoogle Scholar
  9. 9.
    Hauch TW, Rosse WF. Platelet-bound complement (C3) in immune thrombocytopenia. Blood. 1977;50:1129–1136.PubMedGoogle Scholar
  10. 10.
    Tsubakio T, Tani P, Curd JG, McMillan R. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. Br J Haematol. 1986;63:293–300.CrossRefPubMedGoogle Scholar
  11. 11.
    Vainchenker W, Deschamps JF, Bastin JM, et al. Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. Blood. 1982;59:514–521.PubMedPubMedCentralGoogle Scholar
  12. 12.
    McKenna JL, Pisciotta AV. Fluorescence of megakaryocytes in idiopathic thrombocytopenic purpura (ITP) stained with fluorescent antiglobulin serum. Blood. 1962;19:664–674.Google Scholar
  13. 13.
    Joshi BC, Jain NC. Detection of antiplatelet antibody in serum and on megakaryocytes of dogs with autoimmune thrombocytopenia. Am J Vet Res. 1976;37:681–685.PubMedPubMedCentralGoogle Scholar
  14. 14.
    McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA. 1978;239:2460–2462.CrossRefGoogle Scholar
  15. 15.
    Dameshek W, Miller EB. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood. 1946;1:27–52.Google Scholar
  16. 16.
    Diggs LW, Hewlett JS. A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura. Blood. 1948;3:1090–1104.Google Scholar
  17. 17.
    Pisciotta AV, Stefanini M, Dameshek W. Studies on platelets, X: morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood. 1953;8:703–723.Google Scholar
  18. 18.
    Stahl CP, Zucker-Franklin D, McDonald TP. Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood. 1986;67:421–428.Google Scholar
  19. 19.
    Houwerzijl EJ, Blom NR, van der Want JJL, et al. Ultrastructural study shows morphological features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500–506.CrossRefGoogle Scholar
  20. 20.
    Heyns AP, Lotter MG, Badenhorst PN, et al. Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Hematol. 1982;12:167–177.CrossRefPubMedGoogle Scholar
  21. 21.
    Stoll D, Cines DB, Aster RH, Murphy S. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood. 1985;65:584–588.PubMedGoogle Scholar
  22. 22.
    Heyns AP, Badenhorst PN, Lotter MG, Pieters H, Wessels P, Kotze HF. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled and homologous 51Cr-labeled platelets differ. Blood. 1986;67:86–92.Google Scholar
  23. 23.
    Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter S. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence for both impaired platelet production and increased platelet clearance. J Clin Invest. 1987;80:33–40.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Bellucci S, Han ZC, Caen JP. Studies of in vitro megakaryocytopoiesis in adult immune thrombocytopenic purpura (ITP). Eur J Haematol. 1991;47:86–90.CrossRefPubMedGoogle Scholar
  25. 25.
    Abgrall J, Berthou C, Sensebe L, Le Niger C, Escoffre M. Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura. Br J Haematol. 1993;85:803–804.CrossRefPubMedGoogle Scholar
  26. 26.
    Hoffman R, Mazur E, Bruno E, Floyd V. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N Engl J Med. 1981;305:533–538.CrossRefPubMedGoogle Scholar
  27. 27.
    Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003;102:887–895.CrossRefPubMedGoogle Scholar
  28. 28.
    Takahashi R, Sekine N, Nakatake T. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood. 1999;93:1951–1958.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Zauli G, Catani L, Gibellini D, et al. Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br J Haematol. 1996;92:711–717.CrossRefPubMedGoogle Scholar
  30. 30.
    Zauli G, Vitale M, Falcieri E, et al. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood. 1997;90:2234–2243.PubMedGoogle Scholar
  31. 31.
    McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients. Blood. 2004;103:1364–1369.CrossRefPubMedGoogle Scholar
  32. 32.
    Nugent DJ, Kunicki TJ. Autoimmune thrombocytopenic purpura. In: Theofilopoulos A, Bona C, eds. The Molecular Pathology of Autoimmune Diseases. New York, NY: Taylor & Francis; 2002:543–566.Google Scholar
  33. 33.
    Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood. 2002;99:888–897.CrossRefPubMedGoogle Scholar
  34. 34.
    Olsson B, Andersson P, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123–1124.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2005

Authors and Affiliations

  1. 1.The Scripps Research InstituteLa JollaUSA
  2. 2.Children’s Hospital of Orange CountyOrangeUSA

Personalised recommendations